CD8A and neoplasm: By survival analysis, we found that EMTscore could not predict the survival rate of OS patients (Figure 7E), while the infiltration abundance of CD8 T-cells could effectively predict the survival rate of patients (Figure 7F), which conforms to the logic that CD8 T-cells could kill tumor cells for treatment, but unfortunately monocytes could not effectively predict the survival rate (Figure 7G).